TGFB1 and urogenital neoplasm: In these mice, TGF-βblockade, using an anti-TGF-β neutralizingantibody, significantly increased renal expression ofthe NGAL (a kidney injury biomarker), kidneyinfiltration by monocytes/macrophages, andupregulation of MCP-1 expression.